Subjects who are receiving any other investigational agents
Patient is receiving any other investigational agents.
Receiving other investigational agents or not yet completed  days since completion of an investigational study
Subjects may not be receiving any investigational agents within  days prior to start of study treatment
Receiving any other investigational agents
Receiving any other investigational agents
Receiving any other investigational agents for their lymphoma
Participant receiving any other investigational agents within -days of enrollment nor during study participation
Receiving any other investigational agents
Patient must not be receiving any other investigational agents
Subjects who are receiving any other investigational agents. Prior immunotherapy, topotecan and temozolomide are allowed
Patient is receiving other investigational agents
Subjects who are receiving any other investigational agents
Patients receiving any other investigational agents within  days of receiving zydelig
Subjects receiving any other investigational agents
Subjects who are receiving any other investigational agents
Subjects may not be receiving any other investigational agents
Subjects may not be receiving other investigational agents
Subjects receiving any other investigational agents
Receiving any other investigational agents within  days prior to enrollment
Subjects receiving other investigational agents
Subjects receiving any other investigational agents
Subjects receiving any other investigational agents
Subjects receiving any other investigational or standard antineoplastic agents
Subjects who are actively receiving any other investigational agents
Subjects receiving any other investigational agents
Subjects may not be receiving any other investigational agents or anticancer therapies.
Subjects who are receiving any other investigational agents
Patient may be receiving bone targeted agents
Subjects who are receiving any other investigational agents
Subjects may not be receiving any other investigational agents
Subjects receiving any other investigational or standard antineoplastic agents
Subjects is receiving any other investigational agents for the treatment of prostate cancer
Subjects must not be receiving any other investigational agents
Patient must not be receiving any other investigational agents
Subjects receiving any other investigational or standard antineoplastic agents
Receiving any other investigational agents =<  days prior to registration
Subjects who are receiving any other investigational agents
The subject is receiving any other investigational agents
Subjects receiving any other investigational agents
Subjects may not be receiving any other investigational agents
Receiving other investigational agents
May not be receiving any other investigational agents
Subject who is receiving any other investigational agents;
Not receiving any other investigational agents
Subjects receiving any other investigational agents
Receiving any other investigational agents
Receiving any other investigational agents at the time of registration
Subjects receiving any other investigational agents
Patient receiving any other investigational agents
Actively receiving any investigational agents
Subjects receiving other investigational agents are not eligible
May not be receiving any other study agents
Subjects may not be receiving any other investigational agents
Patient receiving any other investigational agents
Patient must not be receiving any other investigational agents
Patient must not be receiving any other investigational agents
Subjects receiving any other investigational agents
Subjects receiving other investigational agents
Receiving any other investigational agents including those for symptom management
Receiving any other investigational agents
Receiving any other investigational agents
Patient may not be receiving any other antineoplastic agents
Receiving any other investigational agents
Patient must not be receiving any other investigational agents
Subjects who are receiving any other investigational agents
Subjects may not be receiving any investigational agents
Patient may be receiving bone targeted agents
Patient must not be receiving any other investigational agents
Patient must not be actively receiving any other investigational agents
Receiving any other investigational agents =<  months prior to registration
Receiving any other investigational agents =<  months prior to Registration
Receiving any other investigational agents
Receiving any other investigational agents
Receiving any other investigational, anticoagulation, and/or chemotherapy agents
Participant is receiving any other investigational agents
Receiving any other investigational agents
Patient may not be receiving any other investigational agents
Women who are receiving any other investigational agents
Receiving any investigational agents
Subjects may not be receiving any investigational agents
